Publication
A reduced form of nicotinamide riboside defines a new path for NAD(+) biosynthesis and acts as an orally bioavailable NAD(+) precursor
Related publications (30)
Giovanni De Cesare, Severin Stähly, Christian Mörtl, Robin Schroff
Cathrin Brisken, Carlos Henrique Venturi Ronchi
Olaf Blanke, Andrea Serino, Tommaso Enrico Bertoni, Nathan Quentin Faivre, Marco Solcà, Pavo Orepic, Gaurav Sharma
Elisabeth Agoritsas, Thierry Giamarchi
Jacques Fellay, Olivier Noël Marie Naret, Flavia Aurelia Shoko Hodel, Clara Bonnet